Skip to main content

What the FDA labels say about taking them together

Fosphenytoin and quetiapine

Fosphenytoin's FDA label of May 18, 2025 names quetiapine in its drug interactions section; the quetiapine labels PlainMeds reads (2) do not name fosphenytoin. The fosphenytoin label: “Interacting Agent: Other; Examples: Albendazole, chlorpropamide, clozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine”

Check it at the source: the fosphenytoin FDA label on DailyMed (effective May 18, 2025, Pfizer Laboratories Div Pfizer Inc); the quetiapine FDA label on DailyMed (effective April 10, 2026, H2-Pharma, LLC).

What does the fosphenytoin label say about quetiapine?

Fosphenytoin label, drug interactions

Interacting Agent: Other; Examples: Albendazole (decreases active metabolite), chlorpropamide, clozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine

Source: FDA drug label (CEREBYX), NDA020450 (Parke Davis), as published by Pfizer Laboratories Div Pfizer Inc, effective May 18, 2025 (SPL set de5a6711-4abb-4c3d-a18b-266b094ace11), via openFDA; the full label on DailyMed

What does the quetiapine label say about fosphenytoin?

Quetiapine's label (effective April 10, 2026) and its 1 other brand-application label do not name fosphenytoin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (SEROQUEL), NDA020639 (Cheplapharm), as published by H2-Pharma, LLC, effective April 10, 2026 (SPL set 8ae62aaf-f8c5-417f-baac-0098369ca322), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Fosphenytoin generic labelers
48Quetiapine generic labelers
FosphenytoinQuetiapine
Labeled forSeizures and epilepsySchizophrenia, Bipolar disorder, Depression
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$0.127 per tablet 300 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?